Submit updated statistical analysis plan to the FDA
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 2 Jun 2025
- Due
- 30 Jun 2025
- Delivered
- July 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“submit updated SAP to the FDA”
What we found
Evidence strength A What the grades mean
The company submitted the final statistical analysis plan to the FDA in July 2025, which occurred after the Q2 2025 deadline.
-
A uniQure N.V. 10-Q filed 2025-07-29
“In July 2025, we submitted the final SAP to the FDA.” ✓ confirmed on the page
Market reaction: the shares moved -6.3% against the S&P 500 over the three sessions around the disclosure (28 Jul 2025 to 31 Jul 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- Submit
- Deliverable
- Updated statistical analysis plan
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-QURE-001911 · Corrections policy